368 related articles for article (PubMed ID: 22858688)
1. Toward personalized cancer nanomedicine - past, present, and future.
Stegh AH
Integr Biol (Camb); 2013 Jan; 5(1):48-65. PubMed ID: 22858688
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles in imaging: paving the way for personalized medicine in the battle against cancer.
Shin SJ; Beech JR; Kelly KA
Integr Biol (Camb); 2013 Jan; 5(1):29-42. PubMed ID: 22790418
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
4. Targeted nanotherapeutics in cancer.
Shiekh FA
Int J Nanomedicine; 2014; 9():1627-8. PubMed ID: 24741302
[No Abstract] [Full Text] [Related]
5. Epigenetics advancing personalized nanomedicine in cancer therapy.
Liu S
Adv Drug Deliv Rev; 2012 Oct; 64(13):1532-43. PubMed ID: 22921595
[TBL] [Abstract][Full Text] [Related]
6. Themed issue on Cancer Nanotechnology.
Grodzinski P
Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
[No Abstract] [Full Text] [Related]
7. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
Choi KY; Liu G; Lee S; Chen X
Nanoscale; 2012 Jan; 4(2):330-42. PubMed ID: 22134683
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer.
Kawasaki ES; Player A
Nanomedicine; 2005 Jun; 1(2):101-9. PubMed ID: 17292064
[TBL] [Abstract][Full Text] [Related]
10. Cancer nanomedicine: from drug delivery to imaging.
Chow EK; Ho D
Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine: perspective and promises with ligand-directed molecular imaging.
Pan D; Lanza GM; Wickline SA; Caruthers SD
Eur J Radiol; 2009 May; 70(2):274-85. PubMed ID: 19268515
[TBL] [Abstract][Full Text] [Related]
12. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
13. The role of nanotechnology in gastrointestinal cancer.
Vyas D; Castro P; Saadeh Y; Vyas A
J Biomed Nanotechnol; 2014 Nov; 10(11):3204-18. PubMed ID: 26000381
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine strategies for molecular targets with MRI and optical imaging.
Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology applications in cancer.
Nie S; Xing Y; Kim GJ; Simons JW
Annu Rev Biomed Eng; 2007; 9():257-88. PubMed ID: 17439359
[TBL] [Abstract][Full Text] [Related]
18. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.
Nehoff H; Parayath NN; Domanovitch L; Taurin S; Greish K
Int J Nanomedicine; 2014; 9():2539-55. PubMed ID: 24904213
[TBL] [Abstract][Full Text] [Related]
20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
